A day in the life… page 4

Article

A day in the life

Previous page

Time to reflect

We usually finish morning clinic between 2 and 2.30 pm, and finally at this point we can relax. During this time we speak of our projects, work in progress, research programmes and participation in upcoming congresses.

One of the best things about our team is the friendliness and comradeship amongst us. It would be very difficult for somebody who has a different work ethic to mix with us. I therefore select our team members very carefully to make sure that their personality, as well as their skills, matches our team. I can honestly say that we are a nice team, and work is certainly more pleasant if the setting is relaxed.

No rest for the wicked

I begin my private practice in the afternoon, usually at 3.00 pm. My office is not in the hospital, but in an historic building very close to the city's cathedral. By the time I arrive, my secretary and my first patients are usually already there.

My practice is retina-oriented, but it is a general ophthalmology practice. My patient base is much smaller than that in the morning clinic, my working rhythm is far more relaxed and thankfully my patients are usually on time for their appointments.

My working day with patients finally comes to an end at around 7.00 pm but I usually stay in my office at least for another hour to read my e-mails, connect to the web, answer letters, and to organise the administrative aspects of my work.

After these tasks, my working day comes to an end and I can recharge my batteries ready for another day at the clinic to begin!

Previous page

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
© 2024 MJH Life Sciences

All rights reserved.